Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxazosin in allergic rhinitis: single versus chronic dosing on nasal airway calibre
2012-005035-85Phase 4Terminated
- Sponsor
- University of Dundee
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxazosin in allergic rhinitis (AR), sponsored by University of Dundee. Started May 2013; status: terminated.
02
Drugs
doxazosin
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2012-005035-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005035-85.